Nifty
:
23581.15
Sensex
:
76070.84
172.35 (0.74%)
567.99 (0.75%)
Nifty
Sensex
:
:
23581.15
76070.84
172.35 (0.74%)
567.99 (0.75%)

Max Healthcare Institute Ltd.

Hospital & Healthcare Services

Rating :
58/99

BSE: 543220 | NSE: MAXHEALTH

NSE BSE
976.40
17-Mar-2026
  • Open
  • High
  • Low
  • Previous Close
  •  976.7
  •  987.7
  •  969.6
  •  970.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2641459
  •  2584285981.3
  •  1314.3
  •  933.8

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 95,002.31
  • 66.94
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 97,222.12
  • 0.15%
  • 9.17

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 23.72%
  • 0.23%
  • 3.13%
  • FII
  • DII
  • Others
  • 50.56%
  • 18.21%
  • 4.15%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.23
  • 22.89
  • 15.49

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 33.34
  • 36.84
  • 8.44

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -0.84

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 72.91
  • 79.57

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.28
  • 10.03

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 46.45
  • 49.14

Earnings Forecasts:

(Updated: 14-03-2026)
Description
2024
2025
2026
2027
Adj EPS
11.07
17.11
21.35
26.49
P/E Ratio
88.20
57.07
45.73
36.86
Revenue
6910.36
10089.5
12201.5
14711
EBITDA
1848.8
2639.55
3285.69
3975.63
Net Income
1075.88
1663.99
2076.12
2572.86
ROA
7.91
10.81
12.24
13.47
P/B Ratio
10.12
8.04
6.91
5.86
ROE
12.1
15.53
16.51
17.42
FCFF
492.72
143.78
860.02
1634.62
FCFF Yield
0.48
0.14
0.84
1.59
Net Debt
2328.4
1987.99
1459.66
97.73
BVPS
96.5
121.4
141.38
166.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Net Sales
2,067.52
1,868.31
10.66%
2,135.47
1,707.46
25.07%
2,027.57
1,542.95
31.41%
1,909.74
1,422.90
34.21%
Expenses
1,529.18
1,369.18
11.69%
1,560.32
1,256.92
24.14%
1,504.66
1,155.54
30.21%
1,398.12
1,040.24
34.40%
EBITDA
538.34
499.13
7.86%
575.15
450.54
27.66%
522.91
387.41
34.98%
511.62
382.66
33.70%
EBIDTM
26.04%
26.72%
26.93%
26.39%
25.79%
25.11%
26.79%
26.89%
Other Income
45.38
33.30
36.28%
32.90
40.84
-19.44%
36.51
34.68
5.28%
46.92
44.12
6.35%
Interest
59.67
52.39
13.90%
53.92
33.54
60.76%
54.85
23.88
129.69%
55.21
20.73
166.33%
Depreciation
111.27
97.54
14.08%
108.10
84.15
28.46%
104.14
76.90
35.42%
100.83
70.32
43.39%
PBT
364.54
308.87
18.02%
446.03
373.69
19.36%
400.43
321.31
24.62%
402.50
335.73
19.89%
Tax
63.62
70.07
-9.21%
-45.27
91.88
-
92.46
85.04
8.73%
83.50
84.19
-0.82%
PAT
300.92
238.80
26.01%
491.30
281.81
74.34%
307.97
236.27
30.35%
319.00
251.54
26.82%
PATM
14.55%
12.78%
23.01%
16.50%
15.19%
15.31%
16.70%
17.68%
EPS
3.09
2.46
25.61%
5.05
2.90
74.14%
3.17
2.43
30.45%
3.28
2.59
26.64%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
8,140.30
7,028.46
5,406.02
4,562.60
3,936.55
2,507.97
1,059.03
1,691.02
1,729.13
1,608.26
1,434.13
Net Sales Growth
24.44%
30.01%
18.49%
15.90%
56.96%
136.82%
-37.37%
-2.20%
7.52%
12.14%
 
Cost Of Goods Sold
1,759.91
1,477.05
1,118.52
922.01
922.90
594.41
217.31
364.46
425.90
423.10
398.71
Gross Profit
6,380.39
5,551.41
4,287.50
3,640.59
3,013.65
1,913.56
841.72
1,326.56
1,303.23
1,185.16
1,035.42
GP Margin
78.38%
78.98%
79.31%
79.79%
76.56%
76.30%
79.48%
78.45%
75.37%
73.69%
72.20%
Total Expenditure
5,992.28
5,188.03
3,924.88
3,335.14
2,998.14
2,124.34
970.38
1,545.51
1,616.35
1,467.93
1,330.54
Power & Fuel Cost
-
115.03
77.54
69.04
62.67
51.37
22.72
46.06
41.36
40.90
40.73
% Of Sales
-
1.64%
1.43%
1.51%
1.59%
2.05%
2.15%
2.72%
2.39%
2.54%
2.84%
Employee Cost
-
1,174.01
934.40
809.35
759.92
588.78
230.13
440.55
422.91
353.47
304.74
% Of Sales
-
16.70%
17.28%
17.74%
19.30%
23.48%
21.73%
26.05%
24.46%
21.98%
21.25%
Manufacturing Exp.
-
1,800.27
1,348.42
1,195.50
995.21
670.35
336.05
112.01
123.23
105.32
20.46
% Of Sales
-
25.61%
24.94%
26.20%
25.28%
26.73%
31.73%
6.62%
7.13%
6.55%
1.43%
General & Admin Exp.
-
507.53
382.92
303.70
226.23
165.14
129.84
563.52
588.57
526.48
472.36
% Of Sales
-
7.22%
7.08%
6.66%
5.75%
6.58%
12.26%
33.32%
34.04%
32.74%
32.94%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
% Of Sales
-
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Miscellaneous Exp.
-
114.14
63.08
35.54
31.21
54.29
34.33
18.91
14.38
18.66
0.00
% Of Sales
-
1.62%
1.17%
0.78%
0.79%
2.16%
3.24%
1.12%
0.83%
1.16%
6.52%
EBITDA
2,148.02
1,840.43
1,481.14
1,227.46
938.41
383.63
88.65
145.51
112.78
140.33
103.59
EBITDA Margin
26.39%
26.19%
27.40%
26.90%
23.84%
15.30%
8.37%
8.60%
6.52%
8.73%
7.22%
Other Income
161.71
164.01
189.05
152.31
131.51
134.97
53.01
66.72
54.52
42.37
36.41
Interest
223.65
165.02
59.89
83.86
100.87
179.46
83.24
101.27
99.37
99.68
67.75
Depreciation
424.34
359.42
244.98
232.19
221.12
174.09
45.64
102.64
94.42
95.51
91.21
PBT
1,613.50
1,480.00
1,365.32
1,063.72
747.93
165.05
12.78
8.32
-26.49
-12.49
-18.96
Tax
194.31
330.49
307.68
-39.79
133.85
45.85
-0.13
8.51
2.24
-11.09
3.65
Tax Rate
12.04%
23.50%
22.54%
-3.74%
18.11%
-66.79%
-1.02%
102.28%
-8.46%
88.79%
-19.25%
PAT
1,419.19
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-3.01
-32.07
-1.40
-22.61
PAT before Minority Interest
1,419.19
1,075.88
1,057.64
1,103.51
605.05
-114.50
12.91
-0.19
-28.73
-1.40
-22.61
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-2.82
-3.34
0.00
0.00
PAT Margin
17.43%
15.31%
19.56%
24.19%
15.37%
-4.57%
1.22%
-0.18%
-1.85%
-0.09%
-1.58%
PAT Growth
40.73%
1.72%
-4.16%
82.38%
-
-
-
-
-
-
 
EPS
14.59
11.06
10.87
11.34
6.22
-1.18
0.13
-0.03
-0.33
-0.01
-0.23

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
9,380.87
8,408.14
7,409.59
6,282.47
5,638.68
2,553.15
963.19
1,166.74
1,192.38
1,145.18
Share Capital
972.14
971.91
970.92
969.61
965.95
537.24
537.24
537.24
537.24
533.41
Total Reserves
8,289.06
7,368.75
6,397.04
5,290.74
4,646.22
2,015.91
425.95
629.50
655.14
611.71
Non-Current Liabilities
3,991.80
2,343.09
1,646.69
2,149.39
2,127.85
410.56
1,251.32
1,792.13
1,646.95
1,494.75
Secured Loans
2,270.06
1,060.33
496.08
628.91
842.32
105.73
889.10
848.57
771.87
648.80
Unsecured Loans
0.00
0.50
0.50
0.50
0.50
0.50
0.96
0.00
0.00
0.00
Long Term Provisions
98.07
75.47
60.48
59.79
60.19
40.66
17.33
15.64
13.59
10.19
Current Liabilities
1,813.77
1,248.71
1,045.57
757.27
776.93
1,009.95
1,140.03
478.09
380.11
422.13
Trade Payables
807.92
633.01
543.46
444.11
435.69
179.63
291.59
266.51
213.72
217.06
Other Current Liabilities
863.43
493.26
408.16
196.95
247.56
95.26
758.66
92.79
65.84
74.42
Short Term Borrowings
63.59
61.29
45.58
74.53
54.25
727.37
73.68
104.36
87.05
120.66
Short Term Provisions
78.83
61.15
48.37
41.68
39.43
7.69
16.10
14.43
13.50
9.99
Total Liabilities
15,186.44
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54
3,304.22
3,146.10
3,045.10
Net Block
11,496.93
8,720.66
7,038.70
7,017.58
6,536.38
850.95
2,192.37
2,227.18
2,244.24
2,272.80
Gross Block
13,337.72
9,902.43
7,958.37
7,759.60
7,099.22
1,252.16
2,557.37
2,464.32
2,422.67
2,356.65
Accumulated Depreciation
1,840.79
1,181.77
919.67
742.02
562.84
401.21
365.00
237.14
178.43
83.85
Non Current Assets
13,593.87
10,293.76
8,158.78
8,188.84
7,418.99
1,058.27
2,907.24
2,872.03
2,796.68
2,754.62
Capital Work in Progress
900.72
553.04
252.43
151.12
26.93
27.55
87.02
38.30
46.14
11.66
Non Current Investment
2.89
2.12
0.51
0.51
0.51
0.00
0.51
0.00
0.00
0.00
Long Term Loans & Adv.
951.31
727.51
673.93
757.17
679.63
70.06
535.51
512.24
373.31
347.47
Other Non Current Assets
237.36
227.40
193.21
262.46
175.54
109.71
91.83
94.31
132.99
122.69
Current Assets
1,592.57
1,706.18
1,943.07
1,000.29
1,124.47
2,915.39
447.30
432.19
349.12
290.48
Current Investments
0.00
0.00
0.00
0.00
0.00
2,182.06
0.00
0.00
0.00
0.00
Inventories
106.21
79.84
76.23
61.36
53.80
26.80
26.01
28.27
23.12
23.22
Sundry Debtors
687.31
462.69
336.12
385.36
365.89
96.09
362.61
257.92
234.82
208.58
Cash & Bank
681.89
1,099.27
1,468.07
499.31
652.92
119.57
11.64
89.97
22.75
13.13
Other Current Assets
117.16
23.46
14.06
23.99
51.86
490.87
47.04
56.03
68.43
45.55
Short Term Loans & Adv.
75.91
40.92
48.59
30.27
37.39
478.76
36.06
42.43
49.64
33.70
Net Current Assets
-221.20
457.47
897.50
243.02
347.54
1,905.44
-692.73
-45.90
-30.99
-131.65
Total Assets
15,186.44
11,999.94
10,101.85
9,189.13
8,543.46
3,973.66
3,354.54
3,304.22
3,145.80
3,045.10

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Cash From Operating Activity
1,459.31
1,121.67
1,284.13
740.52
117.86
77.09
88.95
PBT
1,406.37
1,365.32
1,063.72
738.90
-68.65
12.78
8.32
Adjustment
498.29
184.85
225.84
241.22
504.74
109.44
156.89
Changes in Working Capital
-124.41
-159.22
155.69
-130.54
-376.25
-38.84
-48.13
Cash after chg. in Working capital
1,780.25
1,390.95
1,445.25
849.58
59.84
83.38
117.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-320.94
-269.28
-161.12
-109.06
58.02
-6.29
-28.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,631.74
-1,285.45
-102.32
-763.80
-73.00
-2,640.70
-16.53
Net Fixed Assets
-307.51
-450.46
-140.69
-1,687.37
-2,982.65
557.88
Net Investments
-698.35
-440.62
-27.73
932.29
91.94
-1,701.27
Others
-625.88
-394.37
66.10
-8.72
2,817.71
-1,497.31
Cash from Financing Activity
-163.80
-263.74
-288.56
-294.17
191.33
2,353.12
-73.95
Net Cash Inflow / Outflow
-336.23
-427.52
893.25
-317.45
236.19
-210.49
-1.53
Opening Cash & Equivalents
979.84
1,374.33
480.97
626.59
111.01
321.50
9.13
Closing Cash & Equivalent
661.24
979.71
1,374.33
309.14
626.59
111.01
7.60

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Book Value (Rs.)
95.27
85.82
75.89
64.57
58.10
47.52
17.93
ROA
7.91%
9.57%
11.44%
6.82%
-1.83%
0.35%
-0.01%
ROE
12.22%
13.47%
16.19%
10.19%
-2.80%
0.73%
-0.02%
ROCE
14.67%
16.26%
15.32%
12.38%
2.22%
3.57%
5.32%
Fixed Asset Turnover
0.60
0.61
0.58
0.53
0.60
0.56
0.67
Receivable days
29.86
26.97
28.86
34.83
33.62
79.05
66.97
Inventory Days
4.83
5.27
5.50
5.34
5.87
9.10
5.86
Payable days
178.04
191.96
195.48
173.98
188.92
99.45
94.83
Cash Conversion Cycle
-143.35
-159.72
-161.11
-133.81
-149.44
-11.30
-22.01
Total Debt/Equity
0.27
0.14
0.08
0.12
0.16
0.33
1.05
Interest Cover
9.52
23.80
13.68
8.33
0.62
1.15
1.08

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • Max Healthcare Inst - Quarterly Results
    6th Feb 2026, 00:00 AM

    Read More
  • Max Healthcare Institute reports 26% rise in Q3 consolidated net profit
    5th Feb 2026, 15:10 PM

    Consolidated total income increased by 11.11% at Rs 2,112.90 crore for Q3FY26

    Read More
  • Max Healthcare Institute signs MoU with The Learning Lab
    6th Jan 2026, 15:29 PM

    MoU is for advancing innovative healthcare capacity-building programmes and fostering joint research initiatives

    Read More
  • Max Healthcare to acquire 100% stake in Yerawada Properties
    18th Dec 2025, 14:21 PM

    The board has accorded its approval for setting up a around 450 bedded super speciality hospital on land owned by YPPL

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.